BLOG

Tuesday, May 28, 2019

Natco Pharma slips 8% on weak Q4 results; stock hits new low

The company's consolidated net profit more-than-halved at Rs 120 crore in March quarter against Rs 300 crore in the year-ago quarter.

from Home Page http://bit.ly/2JKgPym
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...